ALAMEDA, Calif., June 5, 2006 (PRIMEZONE) -- Allergy Research Group, Inc. (OTCBB:ALRG) today announced the appointment of Reesa Sokoloff to the position of National Accounts Manager.
"We are pleased to have Reesa onboard to fill this important position. This is the first step to redouble our sales and marketing efforts and to improve our service to our Distributors, Retailer and Professional Customers," said President, Fred Salomon.
Reesa comes to Allergy Research Group with over 11 years experience as a clinical dietitian and nutritional medical consultant. She has run her own private practice, co-authored a book on an all natural sweeteners and lectured to physicians, health care professionals and corporations on topics related to wellness and nutrition. She was also the East Coast Sales Rep for Allergy Research Group from 1998-1999.
Additionally, Reesa has extensive sales and marketing experience and has been the lead consultant for the successful launch of several neutraceutical products for prestigious companies in our industry. Most recently, as Co-Founder and Director of Sales for The Sweet Life, Reesa was responsible for introducing Xylitol, an all natural sweetener, to retailers in the U.S., UK, Canada and Australia.
Reesa received her Master of Science in Clinical Nutrition from New York University and her Bachelor of Science in Food and Business from the State University of New York Oneonta.
"We have an exceptionally talented group at ARG and Reesa will fit in perfectly," said Salomon.
About Allergy Research Group, Inc.
Allergy Research Group, Inc. is an innovative leader in nutraceutical research and product formulation. Since its inception in 1979, the company has been noted for quality, hypoallergenic nutritional supplements and supplies products to physicians and healthcare practitioners worldwide.
Except for historical information contained herein, this release contains, within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, forward-looking statements that are based on management's beliefs and assumptions, current expectations, estimates and projections. Many of the factors that will determine the Company's financial results are beyond the ability of the Company to control or predict. These statements are subject to risks and uncertainties and therefore actual results may differ materially. The Company disclaims any obligation to update any forward-looking statements whether as a result of new information, future events, or otherwise. Important factors and risks that may affect future results include but are not limited to: the impact of competitive products, changes in law and regulations, adequacy and availability of insurance coverage, availability of raw materials, dependence on distributors and customers, dependence on key personnel, litigation, limitations on future financing, the effect of adverse publicity, uncertainties relating to acquisitions, managing and maintaining growth, customer demands, as well as other risks and uncertainties that are described from time to time in the Company's filings with the Securities and Exchange Commission, copies of which are available upon request from the Company's investor relations department or via the SEC's website located at www.sec.gov.
The Allergy Research Group, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=2517